{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:45Z","timestamp":1793395005487,"version":"4.5.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP11\/00090"],"award-info":[{"award-number":["CP11\/00090"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3 Telemarat\u00f3 TV3","award":["559"],"award-info":[{"award-number":["559"]}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["CIG322034"],"award-info":[{"award-number":["CIG322034"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00949"],"award-info":[{"award-number":["PI14\/00949"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179283","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T13:26:27Z","timestamp":1497965187000},"page":"e0179283","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":82,"title":["Metformin intake associates with better cognitive function in patients with Huntington's disease"],"prefix":"10.1371","volume":"12","author":[{"given":"David","family":"Herv\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Forn\u00e9s-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Pilar","family":"G\u00f3mez-Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Sequedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael P.","family":"V\u00e1zquez-Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"key":"ref1","first-page":"65","article-title":"The biological function of the Huntingtin protein and its relevance to Huntington&apos;s Disease pathology","volume":"5","author":"J Schulte","year":"2011","journal-title":"Curr Trends Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/iub.111","article-title":"Protein misfolding inside cells: the case of huntingtin and Huntington&apos;s disease","volume":"60","author":"DM Hatters","year":"2008","journal-title":"IUBMB Life"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington&apos;s disease","volume":"238","author":"M Arrasate","year":"2012","journal-title":"Exp Neurol"},{"key":"ref4","article-title":"Neuropsychiatric symptoms are very common in premanifest and early stage Huntington&apos;s Disease","author":"S Martinez-Horta","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington&apos;s disease decades before diagnosis: the Predict-HD study","volume":"79","author":"JS Paulsen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.57.4.658","article-title":"Clinical markers of early disease in persons near onset of Huntington&apos;s disease","volume":"57","author":"JS Paulsen","year":"2001","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington&apos;s disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"SJ Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref8","article-title":"AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington&apos;s disease","author":"RP Vazquez-Manrique","year":"2015","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2006.10.039","article-title":"Metformin therapy in a transgenic mouse model of Huntington&apos;s disease","volume":"411","author":"TC Ma","year":"2007","journal-title":"Neurosci Lett"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1534","article-title":"Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons","volume":"37","author":"JA Parker","year":"2005","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"F Trettel","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1073\/pnas.1314939111","article-title":"OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin","volume":"111","author":"L Chen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"AK Madiraju","year":"2014","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.bbadis.2014.06.012","article-title":"AMPK-alpha1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington&apos;s disease","volume":"1842","author":"TC Ju","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1083\/jcb.201105010","article-title":"Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington&apos;s disease","volume":"194","author":"TC Ju","year":"2011","journal-title":"J Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"EM Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabres.2013.11.007","article-title":"Diabetes in Europe: an update","volume":"103","author":"T Tamayo","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11892-016-0775-x","article-title":"Diabetes and Cognitive Impairment","volume":"16","author":"LA Zilliox","year":"2016","journal-title":"Curr Diab Rep"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1758-5996-5-6","article-title":"Metformin: an old but still the best treatment for type 2 diabetes","volume":"5","author":"LB Rojas","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e000090","DOI":"10.1136\/bmjdrc-2015-000090","article-title":"The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial","volume":"3","author":"CP Lexis","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1753-0407.2011.00119.x","article-title":"Metformin as an antitumor agent in cancer prevention and treatment","volume":"3","author":"D Li","year":"2011","journal-title":"J Diabetes"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20150497","article-title":"Repurposing metformin: an old drug with new tricks in its binding pockets","volume":"471","author":"R Pryor","year":"2015","journal-title":"Biochem J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jcb.23000","article-title":"Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells","volume":"112","author":"SK Lee","year":"2011","journal-title":"J Cell Biochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI116005","article-title":"Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin","volume":"90","author":"V Sarabia","year":"1992","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"B Viollet","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"MY El-Mir","year":"2000","journal-title":"J Biol Chem"},{"key":"ref27","article-title":"Metformin Prevents Dopaminergic Neuron Death in MPTP\/P-Induced Mouse Model of Parkinson&apos;s Disease via Autophagy and Mitochondrial ROS Clearance","author":"M Lu","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"NA Aziz","year":"2008","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"F Mochel","year":"2007","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington&apos;s disease","volume":"151","author":"V Popovic","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2011.05.006","article-title":"Gastrointestinal dysfunction contributes to weight loss in Huntington&apos;s disease mice","volume":"44","author":"JM van der Burg","year":"2011","journal-title":"Neurobiol Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington&apos;s Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov Disord"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:04:37Z","timestamp":1540339477000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179283"}},"subtitle":[],"editor":[{"given":"Francesc","family":"Palau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179283","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]}}}